Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02541396 · ClinicalTrials.gov registry record · Phase 2
A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy
A Phase 2 study, sponsored by iX Biopharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT02541396 is a Phase 2 study that has completed, run by iX Biopharma. The registered enrollment target is 72 participants.
The verdict
NCT02541396, a Phase 2 study, has completed, sponsored by iX Biopharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of Wafermine administered with and without an opioid medication for acute pain following bunionectomy surgery.
Interventions
- DRUG Placebo
- DRUG Oxycodone
- DRUG Wafermine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2015-10 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02541396
The ClinicalTrials.gov registry entry for NCT02541396 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is iX Biopharma, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02541396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02541396 about?
NCT02541396 is a clinical study titled "A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy". To evaluate the safety and effectiveness of Wafermine administered with and without an opioid medication for acute pain following bunionectomy surgery.
What is the current status of trial NCT02541396?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2015-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02541396?
The interventions under investigation include: Placebo (DRUG), Oxycodone (DRUG), Wafermine (DRUG).
Who is sponsoring clinical trial NCT02541396?
This trial is sponsored by iX Biopharma, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.